Alisa Lask is Director of NEPHROS INC. Currently has a direct ownership of 48,629 shares of NEPH, which is worth approximately $73,429. The most recent transaction as insider was on Dec 13, 2023, when has been sold 9,291 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K
0% 3M change
23.62% 12M change
Total Value Held $73,429

Alisa Lask Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2023
BUY
Grant, award, or other acquisition
-
9,291 Added 16.04%
48,629 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
27,613 Added 41.24%
39,338 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
4,582 Added 28.1%
11,725 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
3,666 Added 33.92%
7,143 Common Stock

Also insider at

RVLP
RVL Pharmaceuticals plc Healthcare
AL

Alisa Lask

Director
Bridgewater, NJ

Track Institutional and Insider Activities on NEPH

Follow NEPHROS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEPH shares.

Notify only if

Insider Trading

Get notified when an Nephros Inc insider buys or sells NEPH shares.

Notify only if

News

Receive news related to NEPHROS INC

Track Activities on NEPH